A Multicentre Phase 3 Trial Comparing Elotuzumab-Cyclophosphamide-Thalidomide-Dexamethasone (E-CTD) with Cyclophosphamide-Thalidomide-Dexamethasone (CTD) for the Treatment of Relapsed and/or Refractory Multiple Myeloma (RRMM) (MM20)
收藏Research Data Australia2024-08-03 收录
下载链接：
https://researchdata.edu.au/a-multicentre-phase-rrmm-mm20/2538345
下载链接
链接失效反馈官方服务：
资源简介：
Dataset includes: Data for 110 patients with relapsed or refractory multiple myeloma, in a randomised controlled trial of Elotuzumab-Cyclophosphamide-Thalidomide-Dexamethasone (E-CTD) with Cyclophosphamide-Thalidomide-Dexamethasone (CTD) Demographic data, diagnostic data, treatment data, outcome data
提供机构：
Health Data Australia Contributor Records
